Discovery of a role of the novel hepatokine, hepassocin, in obesity
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery of a role of the novel hepatokine, hepassocin, in obesity
Authors
Keywords
-
Journal
BIOFACTORS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-10-06
DOI
10.1002/biof.1574
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle
- (2018) Tae Woo Jung et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Obesity-related insulin resistance in adolescents: a systematic review and meta-analysis of observational studies
- (2017) P. Thota et al. GYNECOLOGICAL ENDOCRINOLOGY
- Tumor Necrosis Factor-Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus
- (2017) Muhammad Sajid Hamid Akash et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The Hepatic Protection Effects of Hepassocin in Hyperglycemic Crisis
- (2017) Horng-Yih Ou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Nonalcoholic fatty liver disease (NAFLD) pathophysiology in obese children and adolescents: update
- (2017) Silvana Neves Ferraz de Assunção et al. Nutricion Hospitalaria
- A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes
- (2016) Hung-Tsung Wu et al. DIABETOLOGIA
- Hepassocin is required for hepatic outgrowth during zebrafish hepatogenesis
- (2015) Ming Gao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Patchy progress on obesity prevention: emerging examples, entrenched barriers, and new thinking
- (2015) Christina A Roberto et al. LANCET
- Hepassocin activates the EGFR/ERK cascade and induces proliferation of L02 cells through the Src-dependent pathway
- (2014) Ming Gao et al. CELLULAR SIGNALLING
- The role of Hepassocin in the development of non-alcoholic fatty liver disease
- (2013) Hung-Tsung Wu et al. JOURNAL OF HEPATOLOGY
- Targeted Deletion of Fibrinogen Like Protein 1 Reveals a Novel Role in Energy Substrate Utilization
- (2013) Valeriy Demchev et al. PLoS One
- Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome
- (2012) M. J. Müller et al. Obesity Reviews
- Genetic modifiers of non-alcoholic fatty liver disease progression
- (2011) Quentin M. Anstee et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis
- (2009) Daphne P Guh et al. BMC PUBLIC HEALTH
- Diagnosis and Classification of Diabetes Mellitus
- (2009) DIABETES CARE
- Fibrinogen-like protein 1, a hepatocyte derived protein is an acute phase reactant
- (2007) Zhilin Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now